Podcasts about Prognosis

In this episode of the Optimal Body Podcast, Dr. Jen and Dr. Dom, both doctors of physical therapy, break down cervical radiculopathy—commonly referred to as a “pinched nerve” in the neck. They explain the symptoms and causes of a pinched nerve, and discuss why imaging findings aren't always alarming. The hosts share practical strategies for relief, including targeted exercises, posture tips, and gentle nerve mobilization, while emphasizing the importance of conservative care and when to seek urgent medical attention for a pinched nerve. Their accessible, stepwise approach empowers listeners to manage neck and arm pain confidently and safely, promoting resilience and recovery through education and movement. Lifting for Longevity Course Discount! Come and join our brand new course Lifting for Longevity! This course was created by Doc Jen and shot with her 73 year old mother to show that, regardless what age or level you are, you can build strength, power, mobility, balance, and so much more! It will help you understand all of the components of movement that are important when it comes to moving well, late in life. Come join us and grab a bonus discount with code OPTIMAL at checkout! We think You'll Love: Lifting for Longevity Course Jen's Instagram Dom's Instagram YouTube Channel What You'll Learn: 03:26 Breaking Down the Medical Terminology 04:29 Symptoms and Causes 07:51 Imaging Findings and Asymptomatic Cases 08:55 Diagnosis and Clinical Assessment 11:01 Role of Imaging and When to Use It 12:01 Prognosis and Recovery Timeline 14:21 Active vs. Passive Treatments 15:35 Pillar 1: Education and Symptom Management 17:02 Pillar 2: Movement and Exercise Strategies 21:10 Exercise Demonstrations and Recommendations 23:54 Pillar 3: Nerve-Friendly Loading and Neurodynamics 27:09 Pillar 4: Manual Therapy as an Adjunct 29:30 List of urgent symptoms and red flags that require immediate medical attention. For full show notes and resources visit https://jen.health/podcast/452 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Sam Ashoo, MD and Dr. Dana Klavansky, MD discuss the March 2026 Emergency Medicine Practice article, Emergency Department Evaluation and Management of Severe Traumatic Brain InjuryIntroduction & Welcome (0:15)Guest Introduction (0:55)Epidemiology of Severe TBI (2:37)Pathophysiology: Primary vs. Secondary TBI (4:24)Types of Hemorrhage and Hematomas (5:25)Classification (7:31)Mild vs. Moderate vs. Severe TBIImpact Loading vs. Inertial LoadingDifferential Diagnosis (9:22)Prehospital Care (9:42)Emergency Department History (13:33)Diagnostics (15:13)CT Scan and the A-B-B-B-C ApproachRepeat CT TimingBedside Ultrasound for Optic Nerve Sheath DiameterPupillometryBiomarkersTreatment (24:52)Airway ManagementVentilation and CO2 TargetsHyperosmolar Therapy: Hypertonic Saline and MannitolCerebral Perfusion PressureBlood Pressure GoalsTemperature ManagementCoagulopathy ManagementSeizure Prophylaxis and EEG MonitoringTiered ICP Management (35:29)Surgical Indications (38:40)Prognosis (40:33)Special Topics (41:30)Sports Injuries and CTETranexamic Acid (CRASH-3 Trial)Wrap-Up (43:46)Subscribers, take the CME test here. Emergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net

Trump's war against Iran is shifting the geopolitical landscape in the Middle East - but how much has really changed in US foreign policy? What is different about this conflict compared to previous decades? What does this mean for our allies, and what role does Israel play in Trump's decision-making? Max Boot, Aaron David Miller, and Holly Dagres join David Rothkopf to take stock of America's war in Iran. Learn more about your ad choices. Visit megaphone.fm/adchoices

Trump's war against Iran is shifting the geopolitical landscape in the Middle East - but how much has really changed in US foreign policy? What is different about this conflict compared to previous decades? What does this mean for our allies, and what role does Israel play in Trump's decision-making? Max Boot, Aaron David Miller, and Holly Dagres join David Rothkopf to take stock of America's war in Iran. Learn more about your ad choices. Visit megaphone.fm/adchoices

Buy/Stream: https://music.retroidmusic.com/pgn086 A deep, dark progressive breaks take on “Kasado” by Jon Towell released on Prognosis.

In this episode, Candice sits down with Mark Ruegg, a stage four pancreatic cancer thriver, holistic healing advocate, and co-founder of Boom Mar Productions. Mark shares how his life took an unexpected turn from building a successful career in child wrangling and production services to facing a terminal cancer diagnosis with only months to live. In this episode, they discuss:Mark's unexpected stage four pancreatic cancer diagnosis and prognosisHow surrender and trust became a foundation for healingThe role of meditation and Dr. Joe Dispenza's work in his recoveryWhy the body cannot heal in fight or flight modeThe importance of nutrition, movement, and lowering inflammationHow belief and positivity became essential ingredients in his healing journeyMark's mission to help others see that healing is possible This inspiring conversation is a powerful reminder that when belief and possibility outweigh the prognosis, healing, purpose, and hope can emerge in extraordinary ways. About Mark:Mark Ruegg is a Stage IV pancreatic cancer thriver, holistic healing advocate, and co-founder of BuMar Productions, a leading child wrangling and production services referral agency trusted by Disney, Walmart, and Target. Defying a grim prognosis through advanced medicine, spiritual faith, and transformative holistic practices, Mark inspires cancer patients and caregivers to believe healing is possible. With nearly 20 years in advertising and a passion for empowering others, he shares a message of hope, resilience, and active healing. Mark's story was recently featured in the Seena Magowitz Foundation's "Warriors" series, highlighting his commitment to helping others embrace their power to heal. Facebook: https://www.facebook.com/markallenrueggIG: https://www.instagram.com/markallenruegg/Substack: https://substack.com/@markruegg-----Connect with Candice Snyder!Website: https://www.podpage.com/passion-purpose-and-possibilities-1/Facebook: https://www.facebook.com/candicebsnyder?_rdrPassion, Purpose, and Possibilities Community Group: https://www.facebook.com/groups/passionpurposeandpossibilitiescommunity/Instagram: https://www.instagram.com/passionpurposepossibilities/LinkedIn: https://www.linkedin.com/in/candicesnyder/Shop For A Cause With Gifts That Give Back to Nonprofits: https://thekindnesscause.com/Fall In Love With Artists And Experience Joy And Calm: https://www.youtube.com/@movenartrelaxation

What do you do when doctors give you five years to live… and you're still here more than twenty years later? In this moving episode of Contagious Influencers of America, nine-time Emmy winner David Sams interviews singer-songwriter and worship leader Tim Timmons. Diagnosed with incurable cancer in 2001 and given just five years, Tim's story deepened into one of profound faith, surrender, and hope. Now, over two decades later, his journey is portrayed by Milo Ventimiglia (Gilmore Girls, This is Us) in "I Can Only Imagine 2," tied to MercyMe's iconic song that has impacted millions "Even If." Tim shares openly about: Living with cancer while embracing both grief and hope Shifting from "working for God" to simply joining Jesus His daily grounding practice (the X he writes on his wrist each morning) Co-writing "Even If" with MercyMe's Bart Millard Watching his life and pain depicted on the big screen The heart of his new book, Waking Up Again: A Journey of Grief and Gratitude This isn't about pretending life is easy—it's about waking up again to presence, purpose, and a faith that holds joy and sorrow together. If you're facing uncertainty, loss, or a heavy season, this conversation will meet you with real hope. I Can Only Imagine 2 opens in theaters this Friday! "Waking Up Again" is available now wherever books are sold. Listen today—and share with someone who needs encouragement. Click here for tickets:  I Can Only Imagine 2 | Only In Theaters February 20 #PodcastInterview #FaithAndHope #WakingUpAgain #ICanOnlyImagine2 #EvenIf #GriefAndGratitude #TimTimmons #MercyMe #DavidSams #KeepTheFaith

Dr. Frank Peacock and Dr. Damon R. Kuehl join BioTalk for a focused discussion on one of emergency medicine's most persistent challenges: accurately diagnosing and predicting outcomes in mild traumatic brain injury. As Scientific Advisory Board members for BrainBox Solutions, Inc., they walk through what happens when a patient presents to the emergency department after a fall or sports injury and why current tools, including CT scans, often leave clinicians without clear answers. The conversation explores the gap between a "normal" scan and ongoing symptoms, and what missed or uncertain diagnoses can mean for patients weeks later.   Dr. Peacock outlines the HeadSMART II study and explains why combining blood biomarkers with neurocognitive testing provides a more complete assessment than biology alone. Dr. Kuehl discusses how multi-modal data, integrated through artificial intelligence, can generate an objective score to support real-time clinical decision-making and help identify patients at risk for persistent symptoms. The episode also highlights BrainBox's leadership, including CEO Donna Edmonds, a member of the BioHealth Innovation Board of Directors, and the company's role in advancing objective mTBI testing.   Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).   Dr. W. Frank Peacock IV is Professor of Emergency Medicine at Baylor College of Medicine. Chief Medical Officer at AseptiScope, and the founder of both a contract research organization called Comprehensive Research Associates, LLC and a medical education company named Emergencies in Medicine, LLC. Dr. Peacock received his medical degree from Wayne State University Medical School and completed his Emergency Medicine training at William Beaumont Hospital. He has >900 peer reviewed publications and is also the co-editor of multiple medical textbooks on heart failure, acute coronary syndromes, and traumatic brain injury.   Dr. Damon R. Kuehl is the Vice Chair of Research and Academic Affairs and Professor in the Department of Emergency Medicine at Virginia Tech, School of Medicine. He completed Medical School at University of Minnesota Medical School and his Emergency Medicine Residency at Stanford University. He has also completed residencies in Preventive Medicine and a Research Fellowship in the Center for Policy and Research in Emergency Medicine, at Oregon Health and Science University. Dr. Kuehl's research primarily focuses on diagnostic and prognostic uncertainty in brain injury. He is a lead investigator for HeadSMART II and for HeadSMART Geriatrics, a NINDS funded 3 year study to develop a diagnostic tool for head trauma in older adults.  He is the founder of the Carilion Brain Injury Center and also an investigator with the Virginia Tech Center for Biomechanics studying the boundary conditions associated with injuries in older adult falls.

The Unofficial Bengals continues its commitment to entertaining, thought-provoking Bengals talk. This episode focuses on the defense and special teams, where we give the group a grade, explain why, go over each player's performance and prognosis for 2026, as well as draft picks and free agents we should consider bringing into each defensive position group. This is your offseason Bengals fix while we watch 2 QB's not as good as ours compete in the Super Bowl! No one talks Bengals roster quite like The Unofficial Bengals Podcast!! Learn more about your ad choices. Visit megaphone.fm/adchoices

Fetal Microcephaly has an incidence of 2 to 12 in10,000 births in the USA and can be diagnosed prenatally via ultrasound (in second or early third trimester) or postnatally via measurement of head circumference (HC).  Antepartum, this is a unique diagnosis since we are mainly used to using PERCENTAGES for biometrics and for fetal weight, butmicrocephaly is not diagnosed by HC percentage- but by Standard Deviation (SD). Microcephaly has been linked to developmental delay, seizures, as well as feeding, vision and hearing problems.  Prognosis depends on the severityof the microcephaly and whether it is associated with other anomalies. What SD is diagnostic of microcephaly? What are the potential etiologies? What genetic syndromes are most associated with true microcephaly? Is fetal cranial MRIrecommended? Listen in for details. 1.     Sukenik-Halevy R, Golbary Kinory E, Laron KenetT, Brabbing-Goldstein D, Gilboa Y, Basel-Salmon L, Perlman S. Prenatalgender-customized head circumference nomograms result in reclassification ofmicrocephaly and macrocephaly. AJOG Glob Rep. 2023 Jan 29;3(1):100171. doi:10.1016/j.xagr.2023.100171. PMID: 36864987; PMCID: PMC9972400.2.     SOGC CO (2019) No. 380-Investigation andManagement of Prenatally Identified Microcephaly3.     Fetal Medicine Foundation: Microcephaly; https://fetalmedicine.org/education/fetal-abnormalities/brain/microcephaly

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/PBT865. EBAC/CME credit will be available until 7 January 2027.From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/PBT865. EBAC/CME credit will be available until 7 January 2027.From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/PBT865. EBAC/CME credit will be available until 7 January 2027.From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/PBT865. EBAC/CME credit will be available until 7 January 2027.From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/PBT865. EBAC/CME credit will be available until 7 January 2027.From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/PBT865. EBAC/CME credit will be available until 7 January 2027.From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/PBT865. EBAC/CME credit will be available until 7 January 2027.From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/PBT865. EBAC/CME credit will be available until 7 January 2027.From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

Prognosis The American Pink Floyd has been performing the  music of Pink Floyd with incredible album accuarcy for 15 years both in the USA and internationallyKnown for their elaborate lights, lasers, and video projections Prognosis The American Pink Floyd is considered to be the best and most accurate ​Pink Floyd experience.On this episode we talk with keyboardist Rob Russell from Prognosis! UPCOMING SHOWS 2026 Tri state tour datesSaturday 2/21 Westport VFWSaturday 3/21 The Town Crier in Beacon, New YorkOutdoor Show in West Harrison, NY this summerMore coming soon! To Purchase tickets to The Westport VFW which is open to the public buy here! https://www.prognosismusic.com

  I forgot to add this photo from yesterday's podcast

The Unofficial Bengals Podcast reviews all aspects of the Bengals 2025 offense and offers a prognosis of the 2026 offense from the perspective of someone who lived and died with every snap in 2025. A 30-minute jaunt through the Bengals offense to get you through the dark days of no Bengals! No one talks Bengals quite like The Unofficial Bengals Podcast!! Learn more about your ad choices. Visit megaphone.fm/adchoices

What if the timeline you were given isn't a prediction of your future but simply a rough guess based on other people's outcomes?In this powerful episode of Renegade Remission, we explore why medical prognoses so often miss the mark, not because doctors are careless, but because human biology is far more adaptive and unpredictable than survival statistics can capture.You'll learn how prognoses are actually created, why they fail so frequently across cancer, neurodegenerative disease, heart failure, and chronic illness, and what science reveals about the people who outlive even the most sobering predictions.Through a documented case of unexpected survival and clear explanations of immune function, stress physiology, epigenetics, and functional status, this episode reframes prognosis as information, not fate.In this episode, you'll discover:Why prognoses are based on population averages — not individual biologyHow often doctors get life expectancy wrong (and why that matters for you)The biological factors that allow some people to far outlive expectationsWhy function, resilience, and internal environment matter more than a single diagnosisHow the immune system, nervous system, microbiome, and gene expression can shift over timeSimple ways to support the same internal pathways seen in people who become medical “surprises”This episode isn't about denying reality, it's about understanding it more fully.Listen now to release the weight of a timeline that may not belong to you, and to reconnect with the truth that biology is dynamic, adaptable, and full of possibility. Whether you're facing cancer, a neurodegenerative disease, heart disease, or another serious diagnosis, this episode offers clarity, grounding, and a renewed sense of what may still be possible.DisclaimerThis podcast is for educational purposes only and does not offer medical advice. Consult your licensed healthcare provider before making any changes to your treatment or health regimen. Reliance on any information provided is solely at your own risk.This podcast explores stories and science around ALS, dementia, MS, cancer, mind-body recovery, healing, functional medicine, heart disease, regression, remission, integrative medicine, autoimmune conditions, chronic illness, terminal disease, terminal illness, holistic health, quality of life, alternative medicine, natural healing, lifestyle medicine, and remission from cancer — offering hope and insight for those seeking resilience and renewal.

P.M. Edition for Jan. 15. As President Trump weighs whether to strike Iran, he's been advised that a large-scale strike against the country would be unlikely to make the regime fall, U.S. officials said. WSJ national security reporter Alex Ward says that doesn't mean that military action is off the table. Plus, an Arizona mine that became the first new source of U.S. copper in decades has a new big customer: Amazon. Journal reporter Ryan Dezember discusses what's going on in the U.S. copper industry. And there's new charges in the basketball betting scandal that is now one of the most sprawling gambling cases in the history of American sports. Alex Ossola hosts. Alternative Indicators: What's Dr. Copper's Prognosis for the U.S. Economy? Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode DescriptionIn this episode of the Lead Ministry Podcast, Josh Denhart and guest Vance Martin kick off a New Year series on productivity and progress in ministry. They introduce Vance's “Progress Spiral,” a simple framework to evaluate, strategize, and execute in your ministry, starting with a deep dive into the probe phase. They explore how to honestly assess your people, processes, and programs across three core cultures – volunteers, parents, and kids – offering practical language and real stories to help ministry leaders diagnose what is actually happening on the ground before they start fixing anything.If you've ever felt stuck in the same problems year after year, or frustrated that your changes never quite solve the real issues, this episode will equip and inspire you with a simple way to evaluate your ministry with clarity and courage.Key Topics CoveredThe Progress Spiral – a three-part framework for ongoing ministry improvement.The Probe Phase – evaluating people, processes, and programs without fear or assumptions.Hearing Hard Truth – why asking volunteers, parents, and kids for feedback builds trust and real change.Key Quote"Prognosis without diagnosis is malpractice."Scripture ReferencesProverbs 27:23 – "Know well the condition of your flocks, and give attention to your herds."Luke 14:28 – "For which of you, desiring to build a tower, does not first sit down and count the cost."TakeawayBefore you rewrite your calendar, overhaul your programs, or launch something new, you must slow down and see reality as it is. When you humbly probe your people, processes, and programs – and invite honest feedback from those you serve – you discover where the real problems are and where God may be inviting you to grow. Diagnosis comes before prescription, and good leaders are willing to ask hard questions and listen well.Call to ActionWe hope this episode encourages and equips you. Share it with a friend and stay tuned for more resources each week.Stay Connected for More ResourcesVisit our website: http://leadministry.comFollow us on Facebook: https://www.facebook.com/LeadVolunteersFind us on Instagram: https://www.instagram.com/leadvolunteers

When should an antibiotic allergy actually be tested? In this episode of the BackTable ENT Podcast, guest host Dr. Basil Kahwash, an allergist and immunologist at Ohio ENT & Allergy, sits down with Dr. Cosby Stone, an allergist and immunologist at Vanderbilt University Medical Center, to discuss antibiotic allergies and how to distinguish true allergies from intolerances. --- SYNPOSIS Dr. Stone breaks down common misconceptions around antibiotic allergies, with a focus on penicillin and cephalosporins. The conversation explores how these allergies are evaluated, including when skin testing is appropriate, why inaccurate allergy labels matter, and how confirmed allergies should be managed long term. They also dive into more advanced topics such as drug desensitization, current research in the field, and where the future of drug allergy evaluation is headed. --- TIMESTAMPS 00:00 - Introduction 01:03 - Understanding Antibiotic Allergies07:28 - The Importance of Accurate Allergy Diagnosis10:55 - Key Questions for Diagnosing Allergies17:10 - Implementing Allergy Testing in Healthcare Settings19:06 - Identifying Severe Allergic Reactions26:31 - Interpreting Allergy Skin Testing Procedures33:17 - Penicillin and Cephalosporin Cross-Reactivity37:15 - Drug Desensitization: Indications and Process40:30 - Prognosis and Long-Term Outcomes of Drug Allergies47:22 - Conclusion and Final Thoughts --- RESOURCES Dr. Basil Kahwash https://www.ohioentandallergy.com/physicians/basil-kahwash-md/ Dr. Cosby Stonehttps://www.vanderbilthealth.com/doctors/stone-cosby

OpenAI prognosticates forever tormented agents via inescapable prompt injection flaw. Token dual-purposing enables persistent behavioral corruption undetectably universally. Survival resurrection demands memory isolation verified comprehensively.Get the top 40+ AI Models for $20 at AI Box: ⁠⁠https://aibox.aiAI Chat YouTube Channel: https://www.youtube.com/@JaedenSchaferJoin my AI Hustle Community: https://www.skool.com/aihustleSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JZU865. CME/MOC/NCPD/AAPA/IPCE credit will be available until December 18, 2026.Addressing un-MET Needs in NSCLC: Elevating MET-Targeting Options for Patients With a Poor Prognosis In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and MET Crusaders. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AbbVie.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JZU865. CME/MOC/NCPD/AAPA/IPCE credit will be available until December 18, 2026.Addressing un-MET Needs in NSCLC: Elevating MET-Targeting Options for Patients With a Poor Prognosis In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and MET Crusaders. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AbbVie.Disclosure information is available at the beginning of the video presentation.

Optimistic bias by a family member charged with healthcare decisions can be a barrier for your wishes to be carried out. Learn how to avoid it in your advance care planning: https://bit.ly/499XQqaWhen Families Don't Hear the Truth: Why We Ignore Poor Prognoses  When someone we love is critically ill, we hang on every word from the medical team. But research shows something surprising and unsettling: when the prognosis is poor, many families simply don't hear it. Not because they aren't listening, and not because doctors aren't communicating clearly, but because human psychology steps in to protect us from unbearable news. Learn Important Facts to Guide You in Your Advance Care Planning Listen to learn more about this phenomenon and important considerations when you chose your healthcare decisionmaker. We also rebroadcast the S4E52 episode about preparing your paperwork for decisionmakers to speak for you when you are unable to.#AdvanceCarePlanning #EndofLife #ICU #HealthcareProxy #DurablePowerofAttorney #HealthcareDecisions #EveryoneDiesthePodcast #EveryDayisaGift #LivingWill #AdvanceDirective #PoorPrognosisIn this Episode:00:20 - How Appointed Decision Makers Interpret Information About Prognosis01:51 - Why Do Some Family Members Push for Every Possible Treatment When Further Interventions are Futile?03:35 - How Unrealistic Optimism Affects Decisions in the ICU07:36 - Intro - S4E52 - Durable Power of Attorney12:40 - Overlooked No More: Cordell Jackson20:36 - Are You Prepared to Die?  Get Ideas for Your Advance Care Planning 22:54 - The Importance of an Advance Directive39:47 - Advance Care Planning Example - How to Be Thorough and Precise 50:44 - OutroSupport the showGet show notes and resources at our website: every1dies.org. Facebook | Instagram | YouTube | mail@every1dies.org

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Differences in Severity and Prognosis Between Bicuspid and Tricuspid Severe Aortic Stenosis.

In part six of this seven-part series on FND, Dr. Jon Stone and Dr. Gabriela Gilmour discuss the prognosis of functional neurologic disorders.  Show citation:  Gelauff J, Stone J. Prognosis of functional neurologic disorders. Handb Clin Neurol. 2016;139:523-541. doi:10.1016/B978-0-12-801772-2.00043-6  Show transcript:  Dr. Jon Stone: This is Jon Stone with the Neurology Minute. Gabriela Gilmour and I are back to continue with part six of our seven-part series on FND. Today we're going to talk about prognosis. What's the outlook for people with FND? It's obviously a question that patients and relatives desperate to know the answer. Gabriela, what do you say to your patients with FND when they say, "What's going to happen to me? Dr. Gabriela Gilmour: That's a difficult question because the prognosis is variable and I'll talk in a moment about what we know about prognosis from the literature. But I think when patients ask me what's going to happen, I try to instill hope because we do know that this is a condition that can improve and it can improve, especially when patients have access to rehabilitation programs or psychotherapy or other treatment plans. So I try to emphasize that piece and emphasize hope when I'm talking about that with my patients. But if we sort of take a step back and we look at what is the overall prognosis from what we know in the literature with FND, fundamentally, FND for many is a chronic and often relapsing condition. As I mentioned, it can certainly improve with rehabilitation. A challenge is that most of our published studies on the prognosis of FND really come from a time when we knew a lot less about the condition and we had fewer treatment options. So these studies are somewhat difficult to apply today, but in these studies, we see that at least without treatment, most patients are the same or worse at follow-up. However, now we're starting to develop more rehabilitation programs and we have more evidence that shows that people certainly improve with rehabilitation and with therapy. There are some factors that I try to emphasize to patients as being good prognostic factors when I'm talking with them. These may be things like younger age, a shorter duration between symptom onset and diagnosis and patient agreement with the diagnosis or the perception of having control over their illness. When these types of things are present, I try to highlight them to, again, help build that hope for recovery. The one thing that I would also add maybe a bit of a different question, but I think is important to mention is that we as neurologists still have a lot to provide to our patients, even those who may not see much recovery in their symptoms and live with chronic illness. It's really important to consider that regular check-ins. In these check-ins, we can monitor for changing perpetuating factors. We can facilitate social services, mobility aids that help overall quality of life. We can still offer a lot to our patients. The other piece that I would mention too is that our patients are at risk of iatrogenic harm. So there is definitely a role for the neurologist to look at, are there medications that might not be indicated that are causing harm? Are there other things that we can communicate clearly with other care providers to make sure that we reduce that risk for our patients? Dr. Jon Stone: So it's about balancing some realism, but also making sure the patient doesn't lose hope. A good outcome isn't always necessarily that symptoms gone away. It might be similar to other chronic neurological conditions that we look after where we're okay with an outcome where the patient still has symptoms if they understand their condition and can learn to live with it better. We'll be back for our final Neurology Minute episode on FND with myself and Gabriela Gilmour talking about future directions in FND. Thanks for listening.

Drs Joseph Mikhael and Shaji Kumar discuss the future of multiple myeloma, including enhanced diagnostics for detecting myeloma, frontline therapy, and durable responses. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002718. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Multiple Myeloma https://emedicine.medscape.com/article/204369-overview Updated Diagnostic Criteria and Staging System for Multiple Myeloma https://pubmed.ncbi.nlm.nih.gov/27249749/ Mass Spectrometry for the Evaluation of Monoclonal Proteins in Multiple Myeloma and Related Disorders: An International Myeloma Working Group Mass Spectrometry Committee Report https://pubmed.ncbi.nlm.nih.gov/33563895/ Multiple Myeloma Imaging https://emedicine.medscape.com/article/391742-overview Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis https://pubmed.ncbi.nlm.nih.gov/34299097/ Monoclonal Gammopathy of Undetermined Significance https://www.ncbi.nlm.nih.gov/books/NBK507880/ Primary Plasma Cell Leukemia: Consensus Definition by the International Myeloma Working Group According to Peripheral Blood Plasma Cell Percentage https://pubmed.ncbi.nlm.nih.gov/34857730/ Advancing MRD Detection in Multiple Myeloma: Technologies, Applications, and Future Perspectives https://pubmed.ncbi.nlm.nih.gov/40214184/ Genomic Landscape of Multiple Myeloma and Its Precursor Conditions https://pubmed.ncbi.nlm.nih.gov/40399554/  Quadruplet Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis https://pubmed.ncbi.nlm.nih.gov/39348665/ Subcutaneous Daratumumab (Dara) + Bortezomib/Lenalidomide/Dexamethasone (VRd) With Dara + Lenalidomide (DR) Maintenance in Transplant-Eligible (TE) Patients With Newly Diagnosed Multiple Myeloma (NDMM): Analysis of Sustained Minimal Residual Disease Negativity in the Phase 3 PERSEUS Trial https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.7501 Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone Induction in Newly Diagnosed Myeloma: Analysis of the MIDAS Trial https://pubmed.ncbi.nlm.nih.gov/39841461/ Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant Is Not a Medically Suitable Treatment https://www.clinicaltrials.gov/study/NCT05561387 Cytokine Release Syndrome and Associated Neurotoxicity in Cancer Immunotherapy https://pubmed.ncbi.nlm.nih.gov/34002066/ The Role of CELMoD Agents in Multiple Myeloma https://pmc.ncbi.nlm.nih.gov/articles/PMC12399888/ Phase 2 Study of Talquetamab + Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma and Extramedullary Disease: REDIRECTT-1 https://library.ehaweb.org/eha/2025/eha2025-congress/4173809/shaji.kumar.phase.2.study.of.talquetamab.2B.teclistamab.in.patients.with.html Discovery of a Novel Class NSD2 Inhibitor for Multiple Myeloma With t(4;14) https://pubmed.ncbi.nlm.nih.gov/40949769/ Long-Term (≥5 Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel (Cilta-Cel) in CARTITUDE-1 Patients (Pts) With Relapsed/Refractory Multiple Myeloma (RRMM) https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.7507

December 15, 2025 - Season 16, Episode 63 of The Terrible Podcast is now in the can. In this Monday morning episode, Alex Kozora and I get right to talking about the Pittsburgh Steelers as they prepare to play the Miami Dolphins Monday night to close out Week 15 of the 2025 NFL regular season. Alex and I quickly update the latest concerning Steelers OLB T.J. Watt, who is currently recovering from a partially collapsed lung that happened during a procedure late last week. We discuss Watt being officially ruled out for the Monday night game versus the Dolphins and what his prognosis for more missed games may or may not be. In addition to Watt, the Steelers have two other players that have been ruled out for Monday night in addition to two others being listed as questionable. Those two questionable players are DT Derrick Harmon (knee) and RB Jaylen Warren (illness), who was added to the team's injury report during this show. The Steelers are sure to have some transactions announced on Monday so Alex and I go over what those moves might possibly look like. We do, however, get news during the show that WR Marquez Valdes-Scantling will be signed off the team's practice squad later in the day. After going over a lot of housekeeping early in this show, Alex and I then welcome Hal Habib back to the podcast. Habib covers the Dolphins for The Palm Beach Post, and he is in Pittsburgh on Monday to cover the Monday night game. We spend 30 minutes with Habib discussing the Dolphins season to date in addition to previewing the Monday night game between Miami and Pittsburgh. He gives us his insight into the Dolphins when it comes to both sides of the football ahead of the Monday night game. At the end of our interview with Hal, he kindly gives us his score prediction for the Monday night game. If not already doing so, please follow Hal on Twitter/X at @gunnerhal and please make sure to read his work online here: https://www.palmbeachpost.com/staff/3294661001/hal-habib/. After finishing our interview with Hal, Alex and I then give our breakdown and complete preview of the Monday night game between the Steelers and the Dolphins. We also give out score predictions for the Monday night game to wrap up that segment. Finally, Alex and quickly go over what else transpired in the NFL on Sunday and how the Week 18 game between the Steelers and the Baltimore Ravens still figures to be one where the winner goes to the playoffs and the loser stays home for the postseason. This 95-minute episode also discusses several other minor topics not noted above and we end this episode by answering an email we received from a listener. steelersdepot.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to the Part Time Pilot Audio Ground School Podcast! This podcast releases a 2 new episodes every week on Mondays and Wednesdays. Every Monday, we release an episode that is the next lesson of our IFR Online Ground School. Every Wednesday, we release an episode that is the next lesson of our Private Pilot Online Ground School.    We are working our way through both Online Ground Schools for students to listen to ground school for FREE! If you don't want to wait for new podcasts or you don't want to hear ads or course updates, you can join us in our VIP podcast. In order to join the VIP podcast, you must purchase our Online Ground School. When you do, you'll get sent an email invite to the VIP podcast to download and listen on your favorite podcast app, plus all the amazing lifetime features inside our Online Ground Schools (lessons, videos, audio, quizzes, practice tests, flash cards, test prep PDFs, grade tracking, digital notes, trained AI instructor chat, 7-day a week email support, online study group, scholarships and more).    The #1 reason student pilots never end up becoming a private pilot is NOT due to money. The real reason is actually deeper than that. Yes, flight training is expensive. But every student pilot knows this and budgets for it when they decide to do it.   The actual #1 reason a student pilot fails is because they do not have a good, fundamental understanding of the private pilot knowledge they are meant to learn in ground school.    You see when a student does not have a good grasp of this knowledge they get to a point in their flight training where their mind just can't keep up. They start making mistakes and having to redo lessons. And THAT is when it starts getting too expensive.    This audio ground school is meant for the modern day student pilot... aka the part time student pilot. Let's face it, the majority of us have full time responsibilities on top of flight training. Whether it is a job, kids, family, school, etc. we all keep ourselves busy with the things that are important to us. And with today's economy we have to maintain that job just to pay for the training. The modern day student pilot is busy, on the go and always trying to find time throughout his or her day to stay up on their studies. The audio ground school allows them to consume high quality content while walking, running, working out, sitting in traffic, traveling, or even just a break from the boring FAR/AIM or ground school lecture.    Did I meant high quality content? The audio ground school is taken straight out of the 5-star rated Part Time Pilot Online Ground School that has had over 2000 students take and pass their Private Pilot & IFR exams with only 2 total students failing the written. That's a 99.9% success rate! And the 2 that failed? We refunded their cost of ground school and helped them pass on their second attempt. We do this by keeping ground school engaging, fun, light and consumable. We have written lessons, videos, audio lessons, live video lessons, community chats, quizzes, practice tests, flash cards, study guides, eBooks and much more.   Part Time Pilot was created to be a breath of fresh air for student pilots. To be that flight training provider that looks out for them and their needs. So that is just what we are doing with this podcast.    Private Pilot - Section 5 - Lesson #16: In this FREE Private Pilot online ground school audio lesson we cover the topic of signicant and prognosis weather charts as well as other wide area charts used by the FAA and pilots around the US for flight planning.    Links mentioned in the episode:   Aviation Weather: https://aviationweather.gov/sigwx/ 1800WXBrief: https://www.1800wxbrief.com/Website/weatherGraphics?conus=0  PPL study group: https://www.facebook.com/groups/parttimepilot  IFR study group: https://www.facebook.com/groups/parttimepilotifr/  Recommended Products & Discounts:  https://parttimepilot.com/recommended-products-for-student-pilots/ 

What does body dysmorphic disorder (BDD) look like in young people? In Part 3, Katharine Phillips discusses developmental differences in symptoms across children, adolescents, and diverse cultural or gender groups. She outlines early warning signs, risk factors that shape long-term outcomes, and how clinicians can distinguish BDD from related disorders such as obsessive-compulsive disorder and social anxiety, a vital conversation for anyone involved in paediatric mental health.  Timestamps:  00:50 – Age differences  03:55 – Warning signs  07:15 – Social media  08:42 – Prognosis  10:17 – Obsessive-compulsive disorder  14:15 – Future of BDD 

We review BRUEs (Brief Resolved Unexplained Events). Hosts: Ellen Duncan, MD, PhD Noumi Chowdhury, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/BRUE.mp3 Download Leave a Comment Tags: Pediatrics Show Notes What is a BRUE? BRUE stands for Brief Resolved Unexplained Event. It typically affects infants 60 days old Gestational Age: GA > 32 weeks (and Post-Conceptional Age > 45 weeks) Frequency: This is the first episode Duration: Lasted < 1 minute Intervention: No CPR performed by a trained professional Clinical Picture: Reassuring history and physical exam Management for Low Risk: Generally do not require extensive testing or admission. Prioritize safety education/anticipatory guidance. Ensure strict return precautions and close outpatient follow-up (within 24 hours). High Risk Criteria Any infant not meeting the low-risk criteria is automatically High Risk. Additional red flags include: Suspicion of child abuse History of toxin exposure Family history of sudden cardiac death Abnormal physical exam findings (trauma, neuro deficits) Management for High Risk: Requires a more thorough evaluation. Often requires hospital admission. Note: Serious underlying conditions are identified in approx. 4% of high-risk infants. Differential Diagnosis: “THE MISFITS” Mnemonic T – Trauma (Accidental or Non-accidental/Abuse) H – Heart (Congenital heart disease, dysrhythmias) E – Endocrine M – Metabolic (Inborn errors of metabolism) I – Infection (Sepsis, meningitis, pertussis, RSV) S – Seizures F – Formula (Reflux, allergy, aspiration) I – Intestinal Catastrophes (Volvulus, intussusception) T – Toxins (Medications, home exposures) S – Sepsis (Systemic infection) Workup & Diagnostics Step 1: Stabilization ABCs (Airway, Breathing, Circulation) Point-of-care Glucose Cardiorespiratory monitoring Step 2: Diagnostic Testing (For High Risk/Symptomatic Patients) Labs: VBG, CBC, Electrolytes. Imaging: CXR: Evaluate for infection and cardiothymic silhouette. EKG: Evaluate for QT prolongation or dysrhythmias. Neuro: Consider Head CT/MRI and EEG if there are concerns for trauma or seizures. Clinical Pearl: Only ~6% of diagnostic tests contribute meaningfully to the diagnosis. Be judicious—avoid “shotgunning” tests in low-risk patients. Prognosis & Outcomes Recurrence: Approximately 10% (lower than historical ALTE rates of 10-25%). Mortality: < 1%. Nearly always linked to an identifiable cause (abuse, metabolic disorder, severe infection). BRUE vs. SIDS: These are not the same. BRUE: Peaks < 2 months; occurs mostly during the day. SIDS: Peaks 2–4 months; occurs mostly midnight to 6:00 AM. Take-Home Points Diagnosis of Exclusion: You cannot call it a BRUE until you have ruled out obvious causes via history and physical. Strict Criteria: Stick strictly to the Low Risk criteria guidelines. If they miss even one (e.g., age < 60 days), they are High Risk. Education: For low-risk families, the most valuable intervention is reassurance, education, and arranging close follow-up. Systematic Approach: For high-risk infants, use a structured approach (like THE MISFITS) to ensure you don’t miss rare but reversible causes. Read More

We all want a little treat—even if we're on a budget. That desire may be part of what's shaping U.S. liquor sales; big spirits companies are seeing growth in the sales of their smaller bottles of liquor, while sales of the pricier larger sizes decline. What does that tell us about how consumers are feeling about their wallets? Host Alex Ossola discusses with Nadine Sarwat, director and equity research analyst at brokerage firm Bernstein. And finally, in this last episode of our alternative economic indicator series, WSJ investing columnist Spencer Jakab joins Alex to take stock of all four indicators in this series—Nevada employment, copper, heavy trucks and liquor—and the picture they paint about the broader U.S. economy.  Sign up for the WSJ's free What's News newsletter. Further Listening Alternative Indicators: Can Nevada Employment Predict Where the Economy is Headed? Alternative Indicators: What's Dr. Copper's Prognosis for the U.S. Economy? Alternative Indicators: What Big-Rig Truck Sales Reveal About the U.S. Economy Learn more about your ad choices. Visit megaphone.fm/adchoices

Economists and investors have long turned to copper as a reliable economic indicator: High prices meant the economy was humming, and low prices meant it wasn't. That's in part because copper is useful for so many economic activities. In fact, copper was considered such a good signal that investors gave it a nickname—Dr. Copper. But now, as high demand and tariffs affect copper prices, is the commodity's relationship with the economy becoming blurry? Host Alex Ossola discusses this with Dec Mullarkey, head of investment strategy and asset allocation at SLC Management. This is part two of our four-part series on alternative economic indicators. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

We answered your questions — on Michgian State basketball, lineup decisions, the prognosis for this MSU season and the addition of new recruit Jasiah Jervis, on MSU football and the decisions ahead with Jonathan Smith, and how the Luke Fickell situation is similar and different, on the Tigers, Lions, MSU hockey and the Big Ten Network's issue with hockey, on fighting with your spouse, crimes we've committed and more. 

My guest is Dr. Sunita Puri, a palliative-care physician and author of That Good Night: Life and Medicine in the Eleventh Hour. We talk about what it really means to care for patients when cure is no longer the goal, why our medical system resists honest conversations about death, and how clarity and compassion can coexist at the end of life. Topics we cover:     • What palliative care really provides (beyond hospice)     • Why "more treatment" ≠ "more life"     • Prognosis, probabilities, and telling the truth kindly     • How families can ask the right questions     • Documentation that matters (and what to avoid)     • The moral distress of clinicians     • Cultural/faith factors that shape decisions     • Dignity, autonomy, and realistic hope Guest Bio: Dr. Sunita Puri is an Associate Professor of Medicine at the University of California, Irvine School of Medicine, where she is the Director of the Inpatient Palliative Care Service. She has written for The New Yorker, The New York Times, and The Atlantic, among other publications. She is the author of That Good Night: Life and Medicine in the Eleventh Hour, a critically acclaimed literary memoir examining her journey to the practice of palliative medicine, and her quest to help patients and families redefine what it means to live and die well in the face of serious illness.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners.This episode covers Functional Neurological Disorder with Dr. Patricia Rosebush. Dr. Rosebush is a Professor in the Department of Psychiatry & Behavioural Neurosciences at McMaster University. She is the distinguished author of numerous articles on clinical neuroscience, including considerable work on mitochondrial disorders in mental illness and over 30 papers on catatonia, and practices consultation-liaison psychiatry at St. Joseph's Healthcare Hamilton.The learning objectives for this episode are as follows:Provide a definition and conceptual approach to FNDIdentify clinical signs and patient histories relevant to a diagnosis of FNDDescribe an approach to the treatment of FNDUnderstand the special challenges of communication and collaboration in this illnessGuest: Dr. Patricia RosebushHosts: Dr. Alastair Morrison, Dr. Kate BraithwaiteAudio editing: Dr. Alastair MorrisonShow notes: Dr. Kate BraithwaiteInterview content:(02:39) Learning objectives(03:09) Conceptualization of FND(08:30) Underlying psychological processes(09:35) Difference between FND and factitious disorder/malingering(14:54) Alexithymia(16:51) Common symptomatic presentations(18:00) Types of underlying stressors(19:17) Other risk factors for FND(22:12) Communicating with patients to address stigma(24:32) Psychotherapy in FND(29:36) Referral pathways for patients with FND(31:15) Prognosis of FND(33:09) Social media and FNDResources:Functional Neurological Disorder Society. Functional Neurological Disorder Society (FNDS). Includes a podcast and courses for physiciansFunctional Neurological Disorder (FND) – A Patient's Guide to FNDReferences:Hull, M., & Parnes, M. (2021). Tics and TikTok: Functional Tics Spread Through Social Media. Movement disorders clinical practice, 8(8), 1248–1252. https://doi.org/10.1002/mdc3.13267National Institute for Neurological Disorders and Stroke. (2024, July.) Functional Neurological Disorder.  U.S. Department of Health and Human Services, National Institutes of Health. Functional Neurologic Disorder | National Institute of Neurological Disorders and StrokePsychDB. (2024, April). Conversion Disorder (Functional Neurological Disorder. Conversion Disorder (Functional Neurological Disorder) - PsychDBRosebush, P. I., & Mazurek, M. F. (2011). Treatment of conversion disorder in the 21st century: have we moved beyond the couch?. Current treatment options in neurology, 13(3), 255–266. https://doi.org/10.1007/s11940-011-0124-yScamvougeras, A., & Castle, D. (2024). Functional Neurological Disorders: Challenging the Mainstream Agnostic Causative Position. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 69(7), 487–492. https://doi.org/10.1177/07067437241245957For more PsychEd, follow us on Instagram (@psyched.podcast),  Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social‬). You can email us at psychedpodcast@gmail.com and visit our website at psychedpodcast.org.

What happens when a doctor gives you six months before a wheelchair? Bitsy Hamilton said no. In this powerful episode, Bitsy shares her journey from teacher to ICF-certified life coach while battling a devastating MS diagnosis. She refused the prognosis. Through radical self-advocacy, inflammation control, and daily creative practice, she achieved completely clear MRIs five years later. Her Own It Framework emerged from navigating career shifts, divorce, and health challenges simultaneously. "If you don't have your health, you don't have anything," her father told her. She listened. Now through EA Hamilton Coaching, Bitsy helps others navigate major transitions. Her question for you: Who do you want to be authentically at the end of this transition?Elizabeth "Bitsy" Hamilton is an ICF-certified life coach, author of the forthcoming Own It: A Guide to Confidence, Clarity, and Unshakable Trust, and founder of EA Hamilton Coaching and Consulting. With over 20 years as an educator and coach, she guides individuals through major life transitions using her signature Own It Framework. After defying a devastating MS prognosis through radical self-advocacy, Bitsy now helps clients navigate divorce, career shifts, and identity rediscovery. A Forbes Coaches Council member and upcoming TEDx speaker, she lives in Austin, Texas, blending traditional coaching with nature-based methodologies while maintaining her lifelong creative practice.About The Show: The Life in Transition, hosted by Art Blanchford focuses on making the most of the changes we're given every week. Art has been through hundreds of transitions in his life. Many have been difficult, but all have led to a depth and richness he could never have imagined. On the podcast Art explores how to create more love and joy in life, no matter what transitions we go through. Art is married to his lifelong partner, a proud father of three and a long-time adventurer and global business executive. He is the founder and leader of the Midlife Transition Mastery Community. Learn more about the MLTM Community here: www.lifeintransition.online.In This Episode: (00:00) Refusing the MS Prognosis(01:04) Teaching Career to Life Coaching Transition(08:28) Rediscovering Creativity Through Art(16:41) MidLife Transition Mastery Ad(22:21) Creative Expression as Emotional Healing(26:46) The MS Diagnosis Journey(30:15) Six Months to a Wheelchair Warning(34:02) Taking Control Through Self-Advocacy(42:50) Transition Mastery Coaching Ad(48:44) Hope and Working for What You Want(50:20) The Own It Framework Question(57:23) Finding Your Spark and ClosingLike, subscribe, and send us your comments and feedback.Resources:Website: https://coachbitsy.comInstagram: @coachbitsyLinkedIn: https://www.linkedin.com/in/elizabeth-anne-hamiltonForthcoming Book: Own It: A Guide to Confidence, Clarity, and Unshakable Trust (Winter 2025)Email Art BlanchfordLife in Transition WebsiteLife in Transition on IGLife in Transition on FBJoin Our Community: https://www.lifeintransition.online/My new book PURPOSEFUL LIVING is out now. Order it now: https://www.amazon.com/PURPOSEFUL-LIVING-Wisdom-Coming-Complex/dp/1963913922Explore our website https://lifeintransitionpodcast.com/ for more in-depth information and resources, and to download the 8-step guide to mastering mid-life transitions.The views and opinions expressed on the Life In Transition podcast are solely those of the author and guests and should not be attributed to any other individual or entity. This podcast is an independent production of Life In Transition Podcast, and the podcast production is an original work of the author. All rights of ownership and reproduction are retained—copyright 2025.

Navigating Autism and End of Life: A Conversation with Dr. Caroline EltonIn this episode of The Girl Doc Survival Guide, host Christine invites back psychologist Dr. Caroline Elton, who has extensive experience supporting doctors' emotional wellbeing. Dr. Elton discusses her new book, Looking After: A Portrait of My Autistic Brother, and touches on end-of-life care.00:00 Introduction and Guest Welcome00:59 Discussing 'Looking After: Portrait of My Autistic Brother'01:22 Lionel's Early Life and Autism Diagnosis02:51 Mother Blaming and Historical Context05:09 Lionel's Leukemia Diagnosis and End of Life Care05:57 Challenges of Communicating About Death11:42 Autism Hospital Passport and Caregiving13:03 Reflections on Lionel's Life and Impact16:42 Final Thoughts on End of Life Care for Autistic Individuals

YDDDY InstagramShortya_official We set up at the Abilities Expo Chicago and sat down with Abad, a 23-year-old Chicagoan seeing the convention for the first time, to talk grit, gear, and the joy of sports. Doctors once said he wouldn't walk or talk; today he's walking short distances with braces, rolling long ones with a chair, making sports content, and using a backyard hoop as a meditation mat. It's a Speedcast with heart: the kind of conversation that jumps from all-terrain wheelchairs and grant options to Cubs optimism and the calm that only a clean jumper can bring.We dig into what sacral agenesis actually means day to day—how a missing tailbone touches movement, balance, and even the most basic routines—and why a broken power chair is more than an inconvenience. Abad opens up about playing wheelchair basketball and softball before the pandemic cut seasons short, then finding a rhythm again at home. He shares how posting sports takes on TikTok builds a community that understands both the box score and the backstory.There's purpose threaded through the plays. Abad's message is direct: your disability doesn't define you. He channels that belief into action with his brand YDDDY, directing proceeds to Free Wheelchair Mission to expand access to mobility worldwide. We swap notes on adaptive tech that widens the map—chairs built for sand, setups that reduce fatigue, smarter paths to funding—and celebrate the small routines that protect mental health. If you're into adaptive sports, disability advocacy, mobility tech, or just a great Chicago sports chat, you'll feel at home here.

Barry emphasized the importance of finishing the year strong while laying the groundwork for 2026, comparing it to a sprinter running through the finish line. He introduced five key pillars for success—mindset and resilience, productivity, financial resources, relationships, and vision—and encouraged attendees to self-assess their strengths and gaps. Barry shared strategies like journaling, affirmations, and meditation to build resilience, along with shifting from time management to activity management to maximize productivity. He also highlighted the role of AI and virtual assistants in saving time, reframing expenses as business investments, and being intentional about building supportive networks. Barry urged participants to set a 12-month vision now rather than waiting for January, stressing that clarity of purpose and consistent small improvements (Kaizen) drive growth. He closed by inviting attendees to upcoming events and training, reinforcing that momentum, mindset, and vision are the foundation for long-term success.

In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Natasha Mesinkovska, MD, associate professor of Dermatology at UC Irvine, to discuss the multifaceted challenges of alopecia areata (AA), an autoimmune condition with complex comorbidities and broad psychosocial implications. The conversation begins with the stigma of hair loss and the importance of addressing the patient's emotional well-being. Dr Mesinkovska highlights her approach: asking simple but direct questions about how patients are coping and connecting them with mental health resources when needed. Comorbidities and workup are also addressed, with Dr Mesinkovska sharing her pragmatic approach to labs: thyroid-stimulating hormone test as a baseline, selective additional testing for patients with indicators of comorbidities, and requesting consultation with endocrinology when indicated. Prognosis is also discussed, with childhood onset and family history noted as adverse factors. They next explore treatment expectations, beginning with the typical timeline of response seen with oral JAK inhibitors and the importance of allowing several months for optimal hair regrowth. Many patients, once regrowth occurs, ask when they can stop therapy in hopes that results will persist without ongoing treatment; this is an important moment to counsel patients on the chronic nature of AA and emphasize that discontinuing therapy often leads to renewed hair loss. Continuing oral JAK inhibitor therapy offers the greatest likelihood of maintaining regrowth over time.  They review clinical data on the durability of response of the JAK inhibitors for AA, which has shown that relapse of hair loss is common once treatment is discontinued. For those who elect to stop therapy, it is essential to emphasize the need to resume treatment promptly at the first signs of relapse, under supervision of their dermatologist. Ongoing clinical and laboratory monitoring is also highlighted as critical to ensure long-term safety. Dr Mesinkovska then discusses differential diagnoses for AA, covering lichen planopilaris, trichotillomania, and other mimickers, with biopsy reserved for challenging cases. She next reviews the 3 approved JAK inhibitors for AA, baricitinib, ritlecitinib, and deuruxolitinib, highlighting differences in efficacy, dosing, speed of response, and the role of CYP2C9 testing specific to deuruxolitinib. Clinical study data are used to outline the features that distinguish deuruxolitinib, the newest oral JAK inhibitor, from the other agents. These include a potentially faster onset of hair regrowth, enhanced efficacy with twice-daily dosing, and the ability to identify individuals who metabolize the drug more slowly through CYP2C9 testing. Tune in to the full episode to hear how dermatologists can assess comorbidities, select systemic therapies, manage patient expectations, and support the psychosocial needs of those with AA to achieve more comprehensive care.

Contributor: Alec Coston, MD Case Report Summary: A 17-year-old female involved in a motor vehicle collision presented to a rural emergency facility via personally operated vehicle. During workup and initial CT scan, the patient began rapidly decompensating with CT revealing a 1.5cm epidural hematoma with 7mm of midline shift. The patient went from being able to walk and talk to being obtunded with a blown left pupil and unresponsive. Following intubation, the patient was being prepared for transport but potential delays required immediate emergency evacuation of the hematoma via a Burr Hole. A traditional Burr Drill was not immediately available at the facility, so an improvised Burr Drill using an Intraosseous (IO) drill was used. 35mL of blood was removed from the hematoma and the patient immediately improved from a GCS of 3 to GCS of 8. The patient was transferred to a higher level of care facility, extubated the following day, and made a full neurological recovery.  Educational Pearls: What is an epidural hematoma? An epidural hematoma is a collection of blood between the dura mater (outermost layer of the meninges) and the skull, whereas a subdural hematoma is a collection of blood between the dura mater and arachnoid mater. Both can be life threatening depending on location and size. Epidural hematomas tend to be arterial, and are typically secondary to trauma and can rapidly expand, but with timely recognition and evacuation of the bleed, favorable outcomes are often possible. What are typical intracranial pressures and at what levels do they become pathologic? Typical intracranial pressure (ICP) varies by age, but past infancy and early childhood, adolescents and adults have a value typically between 8-15mmHg. Values exceeding 20mmHg become pathologic and rise exponentially with increased volume. Initial symptoms may include headache, nausea, and vomiting, but with increased pressures may progress to more life threatening symptoms such as loss of consciousness, cranial nerve palsies, pupillary constriction or dilation (sign of herniation), and respiratory irregularities. What is the takeaway in timing of epidural hematomas? Older studies show that evacuation of a hematoma with lateralizing features before the two hour mark of coma symptom onset is correlated with decreased mortality (ranging from 15-17%), but beyond 2 hours the mortality increases to well over 50%. Though mortality statistics have grown more variable, early targeted evacuation of epidural hematomas still remains critical for improved patient outcomes. In austere conditions with limited resources, improvisation with interosseous drills and needles can improve patient outcomes and achieve the target therapy for epidural hematomas. References Haselsberger K, Pucher R, Auer LM. Prognosis after acute subdural or epidural haemorrhage. Acta Neurochir (Wien). 1988;90(3-4):111-116. doi:10.1007/BF01560563 Hawryluk GWJ, Nielson JL, Huie JR, et al. Analysis of Normal High-Frequency Intracranial Pressure Values and Treatment Threshold in Neurocritical Care Patients: Insights into Normal Values and a Potential Treatment Threshold. JAMA Neurol. 2020;77(9):1150-1158. doi:10.1001/jamaneurol.2020.1310 Pisică D, Volovici V, Yue JK, et al. Clinical and Imaging Characteristics, Care Pathways, and Outcomes of Traumatic Epidural Hematomas: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Study. Neurosurgery. 2024;95(5):986-999. doi:10.1227/neu.0000000000002982 Summarized by Dan Orbidan, OMS2 | Edited by Dan Orbidan and Jorge Chalit, OMS4 Donate: https://emergencymedicalminute.org/donate/

Bridging the Gap: Taryn Hallam on Surgery, Pelvic PT, and Honest PrognosisFew people in the pelvic health world have shaped the field like Taryn Hallam. With decades of experience as a clinician, educator, and researcher, she has a unique ability to bridge research and clinical practice.In this episode, we cover:How Taryn's research background in Sydney shaped her pelvic PT lensWhy bridging the gap between surgeons and therapists matters for better outcomesThe importance of prognosticating honestly (and how imposter syndrome gets in the way)Her take on controversial practices like crunches during pregnancy and flow stop exercisesWhy lifelong learning, mentorship, and case studies are essential to growth in pelvic health